Cambrios Technologies, a US-based company developing electronic materials for the display industry formerly known as Semzyme, has raised $2.6m as the first step on an expected $15m round.
The stock is preferred to the $14.5m series D round closed in November last year, according to the company’s regulatory filing first seen by CB Insights.
The investors in the D round were venture capital firms Arch Venture Partners, Alloy Ventures, Oxford Bioscience Partners, Altitude Life Science Ventures, Avalon Ventures, Lux Capital, Kidron and Headland Ventures; investment bank Harris & Harris Group; materials group Chisso; Nissha Printing, he world’s largest manufacturer of touch screens; Japan-based conglomerate Sumitomo and its Presidio Ventures unit and bank Mitsubishi UFJ Capital; US government venture capital firm In-Q-Tel; and property firm Alexandria Real Estate Equities.
The $12m series B round made its initial close in February 2005.